Project cooperationUpdated on 28 August 2025
SSD-004 for Systemic Scleroderma (SSc)
About
SSD-004 (API: 2ccPA) abrogates ECM production and promotes antifibrotic molecules from SSc skin fibroblasts. SSD-004 also at tenuates the progression of fibrosis in bleomycin-induced skin fibrosis. These findings suggest that SSD-004 may be a promising antifibrotic agent for the treatment of SSc.
Stage
- Execution
Type
- Research
- Technical
- Sales/Distribution
- Financing
Attached files
Organisation
Similar opportunities
Project cooperation
SSI-002 for Idiopathic Pulmonary Fibrosis (IPF)
- Research
- Execution
- Technical
- Financing
- Sales/Distribution
Project cooperation
SSH-005 for Hypotrichosis (congenital lack of hair)
- Research
- Execution
- Technical
- Financing
- Sales/Distribution